Evidence map›Paper›PMID 36656301›Full record

ArticleGenesis (New York, N.Y. : 2000)2023

A knockout-first model of H3f3a gene targeting leads to developmental lethality.

Kelly Bush, Vanessa Cervantes, Jennifer Q Yee, Rachel H Klein, Paul S Knoepfler

Open access · greenAbstract read
In one paragraph

Article in Genesis (New York, N.Y. : 2000), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Double jeopardy: howFrontiers in cell and developmental biology · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kelly BushDepartment of Cell Biology and Human Anatomy, University of California Davis, Davis, California, USA.
Vanessa CervantesDepartment of Cell Biology and Human Anatomy, University of California Davis, Davis, California, USA.
Jennifer Q YeeDepartment of Cell Biology and Human Anatomy, University of California Davis, Davis, California, USA.
Rachel H KleinDepartment of Cell Biology and Human Anatomy, University of California Davis, Davis, California, USA.
Paul S KnoepflerDepartment of Cell Biology and Human Anatomy, University of California Davis, Davis, California, USA.ORCID 0000-0001-5444-334X
Shriners Hospitals for Children - Northern California · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Gina M Dayton · 2002 to 2026
$84.9M
Targeting the Mutant H3.3 Pathway in GliomaR01NS106878 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KNOEPFLER, PAUL S · 2018 to 2022
$2.1M
Targeting a Novel H3.3 Epigenetic Switch to Regulate Health and DiseaseR01GM116919 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KNOEPFLER, PAUL S · 2016 to 2019
$1.4M
NCI NIH HHS P30 CA093373NIGMS NIH HHS R01 GM116919NINDS NIH HHS R01 NS106878
6 · The paper itself

Abstract

Histone variant H3.3 is encoded by two genes, H3f3a and H3f3b, which can be expressed differentially depending on tissue type. Previous work in our lab has shown that knockout of H3f3b causes some neonatal lethality and infertility in mice, and chromosomal defects in mouse embryonic fibroblasts (MEFs). Studies of H3f3a and H3f3b null mice by others have produced generally similar phenotypes to what we found in our H3f3b nulls, but the relative impacts of the loss of either H3f3a or H3f3b have varied depending on the approach and genetic background. Here we used a knockout-first approach to target the H3f3a gene for inactivation in C57BL6 mice. Homozygous H3f3a targeting produced a lethal phenotype at or before birth. E13.5 null embryos had some potential morphological differences from WT littermates including smaller size and reduced head size. An E18.5 null embryo was smaller than its control littermates with several potential defects including small head and brain size as well as small lungs, which would be consistent with a late gestation lethal phenotype. Despite a reduction in H3.3 and total H3 protein levels, the only histone H3 post-translational modification in the small panel assessed that was significantly altered was the unique H3.3 mark phospho-Serine31, which was consistently increased in null neurospheres. H3f3a null neurospheres also exhibited consistent gene expression changes including in protocadherins. Overall, our findings are consistent with the model that there are differential, cell-type-specific contributions of H3f3a and H3f3b to H3.3 functions in epigenetic and developmental processes.

Indexed as

FibroblastsHistonesAnimalsEmbryo, MammalianFemaleGene TargetingMiceMice, Inbred C57BLMice, KnockoutMutationPregnancyH3f3a protein, mouseH3f3b protein, mouseHistonesdevelopmentH3f3aH3f3bhistone H3.3mouse knockoutsneurospheres

Identifiers

PMID36656301
PMCPMC10038898
OpenAlexW4317436681

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.